Medical evaluation first
First, the medical team reviews health history, medications, goals, contraindications and the evidence behind a proposed protocol before prescription.
At Skin Works Medical Spa in Torrance, peptide therapy begins with a medical consultation. From there, our team offers consultation-led programs for recovery, body composition, skin support, cognitive goals, longevity and sexual wellness. In addition, the medical team confirms the specific compound, formulation and pharmacy availability before treatment.
Prescription required. Many peptide uses are investigational or off-label. Availability can change with federal/state rules and pharmacy sourcing.

Begin an approved peptide program at the special price shown below. As long as your treatment plan remains active, you keep that price for future prescribed cycles. Importantly, provider-directed rest periods do not interrupt your protected price.
Our Torrance clinic welcomes patients from Redondo Beach, Lomita, Palos Verdes Estates, Rolling Hills Estates, Rancho Palos Verdes, Carson, Gardena, San Pedro and surrounding South Bay communities. During your consultation, our team focuses on your goals, medical history and whether a particular peptide program is medically appropriate.
Peptide therapy in Torrance begins with a medical evaluation, not a one-size-fits-all wellness menu. Peptides are short chains of amino acids involved in many signaling pathways in the body. However, not every marketed peptide has proven clinical benefit. For this reason, the key questions are which compound to consider, what evidence supports the goal, whether the formulation is legally available, and whether it makes sense for the individual.
First, the medical team reviews health history, medications, goals, contraindications and the evidence behind a proposed protocol before prescription.
Compounding rules and pharmacy availability can change. Therefore, treatment must comply with applicable federal and state requirements.
For example, FDA approval of a branded medication for a specific condition does not extend to compounded versions or other uses.
If your provider prescribes a protocol, the team also remains available for administration guidance, follow-up questions and appropriate reassessment.
Many peptides marketed in wellness settings are not FDA-approved drugs. In addition, a licensed pharmacy does not make a compounded medication FDA-approved simply by preparing it.
The programs and prices listed below remain subject to medical review. At consultation, the medical team confirms actual availability, formulation, pharmacy source and prescription; these details may change. Furthermore, FDA-approved tesamorelin and bremelanotide products have narrow labeled indications, so their approval does not extend to other uses.

The clinic discusses programs for soft-tissue recovery, post-procedure support and related goals. However, these compounds are not FDA-approved for these wellness uses, and availability can change.
This clinic-defined compounded blend combines BPC-157 and a TB-500-related peptide for patients exploring recovery support. However, both components remain investigational for these uses and are not FDA-approved drugs.
Discuss this program →BPC-157 is an investigational peptide frequently discussed in recovery settings. However, human evidence remains limited, and it is not FDA-approved. Before treatment, the medical team must confirm the form, prescription and availability.
Discuss this program →TB-500-related peptides are investigational and not FDA-approved. For this reason, the clinic may discuss them for selected recovery goals only after reviewing candidacy, evidence, risks and current pharmacy availability.
Discuss this program →
Options in this category act on or relate to growth-hormone signaling. However, candidacy, laboratory review, risks and regulatory status differ substantially by compound.
The clinic may discuss this compounded growth-hormone-axis combination for selected wellness goals. However, neither compound is FDA-approved for the broad anti-aging or body-composition claims commonly made online. The medical team should also confirm current compounding status.
Discuss this program →Tesamorelin is the active ingredient in Egrifta, an FDA-approved drug for reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. However, it is not FDA-approved as a general weight-loss drug. Therefore, any use outside the approved indication requires separate medical judgment.
Discuss this program →AOD-9604 is an investigational growth-hormone fragment marketed for body-composition goals. However, it is not FDA-approved, and evidence for routine weight-management use remains limited.
Discuss this program →For instance, some compounded protocols use sermorelin, a growth-hormone-releasing hormone analogue. In addition, the medical team reviews current formulation, clinical rationale and pharmacy availability for each patient before prescription.
Discuss this program →
The clinic discusses peptide-based programs alongside aesthetic care. Importantly, formulation matters: injectable and topical/non-injectable products can have different regulatory considerations.
This clinic-defined blend combines GHK-Cu, BPC-157 and a TB-500-related peptide. Because the components have different evidence and regulatory profiles, the medical team confirms formulation and availability at consultation.
Discuss this program →Researchers have studied GHK-Cu, a naturally occurring copper-binding peptide, in skin and wound biology. Because topical/non-injectable and injectable formulations have different regulatory considerations, the clinic confirms formulation availability.
Discuss this program →
Semax and Selank are investigational in the United States and are not FDA-approved drugs. Therefore, any use requires individualized medical review and confirmation of legal pharmacy availability.
Researchers have studied the investigational peptide Semax primarily outside the United States. However, it is not FDA-approved in the U.S., and claims around cognition and neuroprotection remain investigational.
Discuss this program →Similarly, researchers have studied the investigational peptide Selank primarily outside the United States. However, it is not FDA-approved in the U.S. For this reason, the clinic does not present it as a proven replacement for approved anxiety or mood treatments.
Discuss this program →This clinic-defined combination includes Semax and Selank. Because both are investigational in the United States, the medical team reviews evidence, candidacy and current pharmacy availability before any prescription.
Discuss this program →
These programs include investigational compounds with evolving evidence and compounding status. Therefore, a medical consultation is necessary to review suitability, potential risks and current legal availability.
This clinic-defined blend combines GLOW70 with KPV. Because its components are investigational for these wellness uses, the medical team reviews candidacy, evidence, risks and current pharmacy availability before prescription.
Discuss this program →Researchers continue to study MOTS-c, a mitochondrial-derived peptide. However, it is not FDA-approved for metabolic optimization, weight loss or longevity, and human clinical evidence remains limited.
Discuss this program →For example, longevity research includes the investigational peptide Epitalon (Epithalon). However, it is not FDA-approved in the United States, and claims involving telomeres or lifespan remain investigational.
Discuss this program →In addition, researchers have studied thymosin alpha-1 internationally for immune-related indications. However, it is not an FDA-approved drug in the United States. Therefore, its use and availability require individualized medical review.
Discuss this program →
Although bremelanotide is the active ingredient in FDA-approved Vyleesi, that approval covers a specific indication. Other uses do not fall under the labeled Vyleesi indication.
Specifically, the FDA approved Vyleesi (bremelanotide) for acquired, generalized hypoactive sexual desire disorder in premenopausal women. However, Vyleesi is not FDA-approved for men, postmenopausal women, performance enhancement or general libido optimization. Any other use is outside the labeled indication.
Discuss this program →During consultation, your provider considers your goals and makes a clinical decision, including whether peptide therapy should be used at all.
Discuss your goals, health history, medications and the specific program you are interested in.
Your medical provider determines candidacy, current legal/pharmacy availability and whether a prescription is appropriate.
If your provider prescribes a protocol, you receive administration guidance, an appropriate follow-up plan and the special cycle price shown for your selected program.
Peptide therapy should be discussed compound by compound rather than treated as one single category of medicine.
Meet with the Skin Works medical team in Torrance, review what you are trying to improve, and get a clear answer about candidacy, current options, special pricing and whether peptide therapy makes sense for you.
Medical disclaimer: This page is informational and does not constitute medical advice or a prescription. In addition, program availability, formulation, price and pharmacy sourcing may change. In addition, many peptide compounds and wellness uses described on the market are not FDA-approved. Unlike FDA-approved drugs, compounded drugs do not undergo FDA premarketing review for safety, effectiveness or quality. Promotional pricing requires medical approval and applies while the prescribed treatment plan remains active. Provider-directed rest periods do not interrupt rate protection. If a patient stops or allows the program to lapse, the price available at restart applies.